{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:27:30Z","timestamp":1772166450906,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NF22OC0079565"],"award-info":[{"award-number":["NF22OC0079565"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Den f\u00e6lles regionale pulje til forskning i forebyggelse","award":["R201-A4451"],"award-info":[{"award-number":["R201-A4451"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09151-8","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:51:19Z","timestamp":1761659479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Liver Care Trial: screening for liver disease in individuals attending treatment for alcohol use disorder\u2014study protocol for a randomized controlled study"],"prefix":"10.1186","volume":"26","author":[{"given":"Pernille","family":"Dahlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5284-7547","authenticated-orcid":false,"given":"Line","family":"Molzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone Galmstrup","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe","family":"Wegmann D\u00fcring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirstine Skov","family":"Benthien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Winther-Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Christina","family":"Grew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette Wassar","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer Jarlov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gro","family":"Askgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3","key":"9151_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"5","key":"9151_CR2","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/hep.31583","volume":"73","author":"SK Asrani","year":"2021","unstructured":"Asrani SK, Mellinger J, Arab JP, Shah VH. Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action. Hepatol Baltim Md. 2021;73(5):2039\u201350.","journal-title":"Hepatol Baltim Md"},{"key":"9151_CR3","doi-asserted-by":"crossref","unstructured":"Rehm J, Shield KD. Global burden of alcohol use disorders and alcohol liver disease. Biomedicines. 201913;7(4):99.","DOI":"10.3390\/biomedicines7040099"},{"issue":"6","key":"9151_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/ajg.2016.107","volume":"111","author":"T Deleuran","year":"2016","unstructured":"Deleuran T, Vilstrup H, Jepsen P. Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: A Nationwide Cohort Study. Am J Gastroenterol. 2016;111(6):817\u201322.","journal-title":"Am J Gastroenterol"},{"key":"9151_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00192-9","author":"AE Kann","year":"2023","unstructured":"Kann AE, Jepsen P, Madsen LG, West J, Askgaard G. Cause-specific mortality in patients with alcohol-related liver disease in Denmark: a population-based study. Lancet Gastroenterol Hepatol. 2023. https:\/\/doi.org\/10.1016\/S2468-1253(23)00192-9.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"9151_CR6","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/liv.13151","volume":"36","author":"P Jepsen","year":"2016","unstructured":"Jepsen P, Lash TL, Vilstrup H. The clinical course of alcoholic cirrhosis: development of comorbid diseases. A Danish nationwide cohort study. Liver Int. 2016;36(11):1696\u2013703.","journal-title":"Liver Int"},{"key":"9151_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S287870","volume":"13","author":"F Kraglund","year":"2021","unstructured":"Kraglund F, Deleuran T, Askgaard G, Fleming KM, Jepsen P. Decreasing incidence of alcohol-related liver disease in Denmark: a 25-year nationwide study. Clin Epidemiol. 2021;13:1\u201311.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"9151_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","volume":"69","author":"M Thursz","year":"2018","unstructured":"Thursz M, Gual A, Lackner C, Mathurin P, Moreno C, Spahr L, et al. EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018;69(1):154\u201381.","journal-title":"J Hepatol"},{"issue":"1","key":"9151_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.gastro.2015.09.040","volume":"150","author":"M Thiele","year":"2016","unstructured":"Thiele M, Detlefsen S, Sevelsted M\u00f8ller L, Madsen BS, Fuglsang Hansen J, Fialla AD, et al. Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis. Gastroenterology. 2016;150(1):123\u201333.","journal-title":"Gastroenterology"},{"issue":"1","key":"9151_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/pubmed\/fdq050","volume":"33","author":"M Deutekom","year":"2011","unstructured":"Deutekom M, Vansenne F, McCaffery K, Essink-Bot ML, Stronks K, Bossuyt PMM. The effects of screening on health behaviour: a summary of the results of randomized controlled trials. J Public Health. 2011;33(1):71\u20139.","journal-title":"J Public Health"},{"issue":"1","key":"9151_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.32163","volume":"75","author":"P Gin\u00e8s","year":"2022","unstructured":"Gin\u00e8s P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, et al. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022;75(1):219\u201328.","journal-title":"Hepatology"},{"issue":"4","key":"9151_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/acer.13981","volume":"43","author":"P Sarich","year":"2019","unstructured":"Sarich P, Canfell K, Banks E, Paige E, Egger S, Joshy G, et al. A Prospective Study of Health Conditions Related to Alcohol Consumption Cessation Among 97,852 Drinkers Aged 45 and Over in Australia. Alcohol Clin Exp Res. 2019;43(4):710\u201321.","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"9151_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1530-0277.2009.00905.x","volume":"33","author":"CC DiClemente","year":"2009","unstructured":"DiClemente CC, Doyle SR, Donovan D. Predicting treatment seekers\u2019 readiness to change their drinking behavior in the COMBINE Study. Alcohol Clin Exp Res. 2009;33(5):879\u201392.","journal-title":"Alcohol Clin Exp Res"},{"key":"9151_CR14","doi-asserted-by":"crossref","unstructured":"Sheron N, Moore M, O\u2019Brien W, Harris S, Roderick P. Feasibility of detection and intervention for alcohol-related liver disease in the community: the alcohol and liver disease detection study (ALDDes). Br J Gen Pract. 2013;63(615):e698-705.","DOI":"10.3399\/bjgp13X673711"},{"issue":"1","key":"9151_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pcd.2023.10.011","volume":"18","author":"A Gourlay","year":"2024","unstructured":"Gourlay A, Sutherland C, Radley A. Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing diabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2024;18(1):7\u201316.","journal-title":"Prim Care Diabetes"},{"key":"9151_CR16","doi-asserted-by":"crossref","unstructured":"Tammem\u00e4gi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst. 2014;106(6):dju084.","DOI":"10.1093\/jnci\/dju084"},{"issue":"7454","key":"9151_CR17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.","journal-title":"BMJ"},{"issue":"4","key":"9151_CR18","first-page":"477","volume":"5","author":"IK Larsen","year":"2007","unstructured":"Larsen IK, Grotmol T, Almendingen K, Hoff G. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2007;5(4):477\u201383.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"4","key":"9151_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/bjhp.12265","volume":"22","author":"GC Cooper","year":"2017","unstructured":"Cooper GC, Harvie MN, French DP. Do negative screening test results cause false reassurance? A systematic review. Br J Health Psychol. 2017;22(4):958\u201377.","journal-title":"Br J Health Psychol"},{"key":"9151_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-603","author":"RE Collins","year":"2011","unstructured":"Collins RE, Lopez LM, Marteau TM. Emotional impact of screening: a systematic review and meta-analysis. BMC Public Health. 2011. https:\/\/doi.org\/10.1186\/1471-2458-11-603.","journal-title":"BMC Public Health"},{"issue":"1","key":"9151_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.amjmed.2014.07.043","volume":"128","author":"JF Kelly","year":"2015","unstructured":"Kelly JF, Wakeman SE, Saitz R. Stop talking \u2018dirty\u2019: clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015;128(1):8\u20139.","journal-title":"Am J Med"},{"issue":"12","key":"9151_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","volume":"104","author":"ZS Morris","year":"2011","unstructured":"Morris ZS, wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510\u201320.","journal-title":"J R Soc Med"},{"issue":"3","key":"9151_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3152\/147154403781776618","volume":"12","author":"J Grant","year":"2003","unstructured":"Grant J, Green L, Mason B. Basic reserach and health: a reassessment of the scientific basis for the support of biomedical science. Res Evol. 2003;12(3):217\u201324.","journal-title":"Res Evol"},{"issue":"7","key":"9151_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2017-019562","volume":"8","author":"KK Antonsen","year":"2018","unstructured":"Antonsen KK, Klausen MK, Brunchmann AS, Le Dous N, Jensen ME, Miskowiak KW, et al. Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: Study protocol of a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open. 2018;8(7):1\u20138.","journal-title":"BMJ Open"},{"issue":"19","key":"9151_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.159863","volume":"7","author":"MK Klausen","year":"2022","unstructured":"Klausen MK, Jensen ME, M\u00f8ller M, Le Dous N, Jensen AM\u00d8, Zeeman VA, et al. Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial. JCI Insight. 2022;7(19):1\u201319.","journal-title":"JCI Insight"},{"key":"9151_CR26","unstructured":"National Collaborating Centre for Mental Health (Great Britain), National Institute for Health and Clinical Excellence (Great Britain), British Psychological Society., Royal College of Psychiatrists. Alcohol-use disorders\u202f: diagnosis, assessment, and management of harmful drinking and alcohol dependence. British Psychological Society; 2011. p. 612."},{"key":"9151_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CLEP.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, Sundb\u00f8ll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563\u201391.","journal-title":"Clin Epidemiol"},{"key":"9151_CR28","unstructured":"Alkohol. Available from: https:\/\/www.esundhed.dk\/Emner\/Hvad-doer-vi-af\/Alkohol. Cited 2025 May 23."},{"issue":"3","key":"9151_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti A, Tsochatzis E, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update. J Hepatol. 2021;75(3):659\u201389.","journal-title":"J Hepatol"},{"issue":"11","key":"9151_CR30","doi-asserted-by":"publisher","first-page":"14788","DOI":"10.3390\/ijms131114788","volume":"13","author":"G Viel","year":"2012","unstructured":"Viel G, Boscolo-Berto R, Cecchetto G, Fais P, Nalesso A, Ferrara SD. Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. Int J Mol Sci. 2012;13(11):14788\u2013812.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9151_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"6","key":"9151_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1037\/a0016830","volume":"64","author":"WR Miller","year":"2009","unstructured":"Miller WR, Rose GS. Toward a theory of motivational interviewing. Am Psychol. 2009;64(6):527\u201337.","journal-title":"Am Psychol"},{"key":"9151_CR33","unstructured":"European Commission Health Promotion Knowledge Gateway. National low drinking recommendation (or drinking guidelines) and standard units. Available from: https:\/\/knowledge4policy.ec.europa.eu\/health-promotion-knowledge-gateway\/national-low-risk-drinking-recommendations-drinking-guidelines_en. Cited 2024 May 24."},{"issue":"4","key":"9151_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","volume":"56","author":"MJ Bohn","year":"1995","unstructured":"Bohn MJ, Babor TF, Kranzler HR. The alcohol use disorders identification test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56(4):423\u201332.","journal-title":"J Stud Alcohol"},{"issue":"3","key":"9151_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware","year":"1996","unstructured":"Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"issue":"84","key":"9151_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jpsychores.2016.03.009","volume":"1","author":"MG Nielsen","year":"2016","unstructured":"Nielsen MG, \u00d8rnb\u00f8l E, Vestergaard M, Bech P, Larsen FB, Lasgaard M, et al. The construct validity of the Perceived Stress Scale. J Psychosom Res. 2016;1(84):22\u201330.","journal-title":"J Psychosom Res"},{"key":"9151_CR37","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/liv.13408","volume":"37","author":"F \u00c5berg","year":"2017","unstructured":"\u00c5berg F. Binge drinking and the risk of liver events a population-based cohort study. Liver Int. 2017;37:1373\u201381.","journal-title":"Liver Int"},{"key":"9151_CR38","unstructured":"National Institute of Health - drinking levels. Available from: https:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/moderate-binge-drinking. Cited 2024 Apr 4."},{"issue":"1","key":"9151_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40814-024-01504-5","volume":"10","author":"P Jepsen","year":"2024","unstructured":"Jepsen P, von Wowern N, Madsen LG, Klausen MK, D\u00fcring S, Benthien KS, et al. The LIVER CARE trial \u2014 screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trial. Pilot Feasibility Stud. 2024;10(1):78.","journal-title":"Pilot Feasibility Stud"},{"issue":"1","key":"9151_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/add.14795","volume":"115","author":"K Andersen","year":"2020","unstructured":"Andersen K, Behrendt S, Bilberg R, Bogenschutz MP, Braun B, Buehringer G, et al. Evaluation of adding the community reinforcement approach to motivational enhancement therapy for adults aged 60 years and older with DSM-5 alcohol use disorder: a randomized controlled trial. Addict Abingdon Engl. 2020;115(1):69\u201381.","journal-title":"Addict Abingdon Engl"},{"issue":"1","key":"9151_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0376-8716(96)01263-X","volume":"42","author":"LC Sobell","year":"1996","unstructured":"Sobell LC, Brown J, Leo GI, Sobell MB. The reliability of the alcohol timeline followback when administered by telephone and by computer. Drug Alcohol Depend. 1996;42(1):49\u201354.","journal-title":"Drug Alcohol Depend"},{"key":"9151_CR42","unstructured":"Riessman CK. Narrative Analysis. Newbury Park, London, New Delhi: Sage Publications; 1993."},{"key":"9151_CR43","unstructured":"Riessman CK. Narrative Methods for the Human Sciences. Los Angeles, London, New Delhi, Singapore: Sage Publications; 2007."},{"issue":"1","key":"9151_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-017-0605-9","volume":"12","author":"L Atkins","year":"2017","unstructured":"Atkins L, Francis J, Islam R, O\u2019Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):1\u201318.","journal-title":"Implement Sci"},{"key":"9151_CR45","doi-asserted-by":"crossref","unstructured":"Cane J, O\u2019Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37.","DOI":"10.1186\/1748-5908-7-37"},{"key":"9151_CR46","doi-asserted-by":"crossref","unstructured":"Nilsen P, Birken SA. Handbook on Implementation Science. Cheltenham, Northampton: Edward Elgar Publising; 2020.","DOI":"10.4337\/9781788975995"},{"issue":"13","key":"9151_CR47","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided by Information Power. Qual Health Res. 2016;26(13):1753\u201360.","journal-title":"Qual Health Res"},{"key":"9151_CR48","doi-asserted-by":"crossref","unstructured":"Hjollund NH, Larsen FB, Andersen JH. Register-based follow-up of social benefits and other transfer payments: accuracy and degree of completeness in a Danish interdepartmental administrative database compared with a population-based survey. Scand J Public Health. 2007;35(5):497-502.","DOI":"10.1080\/14034940701271882"},{"issue":"2","key":"9151_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"9151_CR50","unstructured":"World Health Organization. Increase effectiveness, maximize benefits and minimize harm Screening programmes: a short guide. 2020."},{"issue":"6","key":"9151_CR51","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1093\/ije\/dyv183","volume":"44","author":"JO Younge","year":"2015","unstructured":"Younge JO, Kouwenhoven-Pasmooij TA, Freak-Poli R, Roos-Hesselink JW, Hunink MGM. Randomized study designs for lifestyle interventions: a tutorial. Int J Epidemiol. 2015;44(6):2006\u201319.","journal-title":"Int J Epidemiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09151-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09151-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09151-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:04:33Z","timestamp":1761699873000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09151-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9151"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09151-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4609877\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Committee on Health Research Ethics of Region Zealand, Denmark (Project ID: SJ-995, EMN-2022\u201305916). The protocol is available at clinicaltrials.gov. All participants provided written informed consent and were not offered financial compensation. The study was conducted under the Helsinki Declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"The results will be published regardless of whether they are positive, negative or inconclusive via\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"448"}}